EP Patent

EP0982027A1 — Taxoid derivatives for treating abnormal cell proliferation of the brain

Assigned to Aventis Pharma SA · Expires 2000-03-01 · 26y expired

What this patent protects

The present invention relates a new use of taxoid derivatives. It relates more precisely a method for treating abnormal cell proliferation in the brain of mammals including men by administrating a taxoid derivative.

USPTO Abstract

The present invention relates a new use of taxoid derivatives. It relates more precisely a method for treating abnormal cell proliferation in the brain of mammals including men by administrating a taxoid derivative.

Drugs covered by this patent

Patent Metadata

Patent number
EP0982027A1
Jurisdiction
EP
Classification
—
Expires
2000-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Aventis Pharma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.